Riskpilot← Back to searchSign inGet full accessBIOTEC BETAGLUCANS AS
ASActiveOrg 996327191Stakkevollvegen 65, 9010 TromsøManufacture of other organic basic chemicals · NACE 2014Est. 201115 employeeswww.biotec.no
Revenue 2025
NOK 45,9M
+41% vs 2024
EBITDA margin
17.5%
+91% vs 2024
Equity ratio
51.9%
Financial strength
Net profit 2025
NOK 7,7M
+125% vs 2024
| Revenue | NOK 45,9M | +41% |
| EBITDA | NOK 8M | +91% |
| Net profit | NOK 7,7M | +125% |
| Total assets | NOK 34M | +2% |
| Equity | NOK 17,7M | +26% |
| Employees | 15 | — |
Legal name
BIOTEC BETAGLUCANS AS
Org number
996327191
Legal form
Aksjeselskap
NACE code
2014 · Manufacture of other organic basic chemicals
Founded
5. januar 2011
Share capital
NOK 1 000 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Forskning, utvikling, produksjon, markedsføring og salg av aktive immunmodulerende ingredienser til bruk i farmasøytiske spesialpreparater, medisinsk-teknisk utstyr, helsekost, kosmetikk, «functional food» og fôr-produkter. Selskapet skal fremme utvikling av produkter og teknologisk viten innenfor sine virksomhetsområder, og skal kunne gjøre investeringer i andre selskaper innenfor disse områdene.
Address
Stakkevollvegen 65, 9010 Tromsø
Phone
+4777648900
Email
contact@biotec.no
Website
www.biotec.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 49 836 | 90 778 | 23 473 | 32 462 | 45 861 |
| Staff expenses | −8 172 | −7 905 | −8 911 | −10 002 | −11 221 |
| EBITDA | 13 292 | 66 790 | 2 426 | 4 199 | 8 009 |
| Depreciation & amort. | −12 844 | −1 496 | −501 | −586 | −575 |
| EBIT | 448 | 65 294 | 1 925 | 3 613 | 7 434 |
| Net financials | 138 | 844 | 433 | −196 | 262 |
| Profit before tax | 587 | 66 138 | 2 359 | 3 417 | 7 696 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 587 | 66 138 | 2 359 | 3 417 | 7 696 |
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 26 104 | 26 288 | 22 608 | 33 234 | 34 044 |
| Equity | 22 072 | 17 210 | 13 569 | 13 986 | 17 681 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 032 | 9 078 | 9 039 | 19 248 | 16 363 |
| Total debt | 4 032 | 9 078 | 9 039 | 19 248 | 16 363 |
EBITDA margin
17.5%
This company
15.8%
Market median
+11% vs market
20202025
Equity ratio
51.9%
This company
38.2%
Market median
+36% vs market
20202025
Return on equity
43.5%
This company
18.4%
Market median
+136% vs market
20202025
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
20202025
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20202025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20202025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2022-01-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MV Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danstar Ferment Ag | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOTEC BETAGLUCANS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Vinge | Chief Executive Officer | 0 companies |
| Francisco Pereira Da Conceicoa | Chairman | 0 companies |
| Rolf Einar Engstad | Board of Directors | 0 companies |
| Per Henrik Larsen | Board of Directors | 0 companies |
| Francois Leblanc | Chairman | 0 companies |
| Michael Omvik-Grotkjær | Board of Directors | 0 companies |
| Andre Lambert | Board of Directors | 0 companies |
| Robert Cornelis Lucas Compier | Board of Directors | 0 companies |